Julien Dusonchet

发表

A Rat Model of Progressive Nigral Neurodegeneration Induced by the Parkinson's Disease-Associated G2019S Mutation in LRRK2

P. Aebischer, R. Zufferey, O. Kochubey, 2011, The Journal of Neuroscience.

Sustained expression of PGC-1α in the rat nigrostriatal system selectively impairs dopaminergic function

P. Aebischer, B. Schneider, C. Ciron, 2012, Human molecular genetics.

Adenoviral-mediated expression of G2019S LRRK2 induces striatal pathology in a kinase-dependent manner in a rat model of Parkinson's disease

P. Colin, B. Schneider, D. Moore, 2015, Neurobiology of Disease.

A Parkinson's disease gene regulatory network identifies the signaling protein RGS2 as a modulator of LRRK2 activity and neuronal toxicity.

J. Collins, Hu Li, M. Glicksman, 2014, Human molecular genetics.

Interaction of LRRK2 with kinase and GTPase signaling cascades

B. Wolozin, J. Dusonchet, Joon Y. Boon, 2014, Front. Mol. Neurosci..

Metabolic regulation of the pancreatic beta-cell ATP-sensitive K+ channel: a pas de deux.

F. Ashcroft, A. Tarasov, J. Dusonchet, 2004, Diabetes.

Metabolic Regulation of the Pancreatic -Cell ATP-Sensitive K Channel

F. Ashcroft, A. Tarasov, J. Dusonchet, 2004 .

Exogenous LRRK2G2019S induces parkinsonian-like pathology in a nonhuman primate.

S. Trouche, S. Salinas, E. Kremer, 2018, JCI insight.

Targeted overexpression of the parkin substrate Pael-R in the nigrostriatal system of adult rats to model Parkinson's disease

P. Aebischer, B. Schneider, J. Bensadoun, 2009, Neurobiology of Disease.